Dr. Prem Premsrirut

Founder and CEO at mirimus
On the record
Represented by:

Experienced CEO with a demonstrated history of working in the biotechnology industry. Skilled in Molecular Biology, Biotechnology, Cell Culture, Polymerase Chain Reaction (PCR), and Research and Development (R&D). Strong business development professional with a Entrepreneurship focused in Business Administration, Management and Operations from Goldman Sach's 10K Small Business Program.

Recent Quotes
Sign up to view all
  • We are pleased to be working with CoVerified to provide a highly effective, efficient and cost-effective solution to COVID-19 surveillance testing and welcome the opportunity to expand this program to schools across the country. Even as the rollout of COVID-19 vaccines continues, robust surveillance testing is key to ensuring a safe learning environment.

    21 May 2021
  • Saliva-based sampling is simple, safe and noninvasive, and is just as effective as testing nasal pharyngeal swabs, according to studies conducted by Yale University. Unlike intranasal swabs or blood samples, saliva samples can be easily and painlessly self-collected without the need for needles, nose swabs or medical personnel.

    21 May 2021
  • If we have a robust testing pipeline, where you can give your sample and have the results provided back to you within 12 to 24 hours, and have meaningful results, we can really start to control the spread of this.

    21 May 2021
Sign up to view all
  • mirimus
    Founder and CEO